Your browser doesn't support javascript.
loading
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.
Bozonnat, Alizée; Assan, Florence; LeGoff, Jérôme; Bourrat, Emmanuelle; Bachelez, Hervé.
Afiliação
  • Bozonnat A; Department of General Pediatrics, Infectious Disease and Internal Medicine, Hôpital Robert Debré, AP-HP, Paris, France.
  • Assan F; Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Saint Louis, ), Hôpital Saint-Louis, AP-HP, Paris, France.
  • LeGoff J; Laboratory of Genetics of Skin Diseases, INSERM U1163, Imagine Institute, Université de Paris, Paris, France.
  • Bourrat E; Department of Virology, Hôpital Saint-Louis, AP-HP, Université de Paris, Paris, France.
  • Bachelez H; Department of General Pediatrics, Infectious Disease and Internal Medicine, Hôpital Robert Debré, AP-HP, Paris, France.
J Clin Immunol ; 41(7): 1511-1514, 2021 10.
Article em En | MEDLINE | ID: mdl-34176064

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Interleucinas / SARS-CoV-2 / COVID-19 / Mutação Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Interleucinas / SARS-CoV-2 / COVID-19 / Mutação Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article